BACKGROUND AND PURPOSE: CAS carries an inherent risk of distal cerebral embolization, precipitating new brain ischemic lesions and neurologic symptoms. Our purpose was to evaluate the frequency of new ischemic lesions found on DWI after protected CAS placement and to determine its association with plaque morphology. MATERIALS AND METHODS: Fifty patients (mean age 65.13 ± 7.08 years) with moderate and severe internal carotid artery stenosis underwent CAS with distal filter protection. Fibrolipid and fibrocalcified plaque morphology was determined by sonography according to the relative contribution of echogenic and echolucent material, and by multisection CT using plaque attenuation. There were 46.81% of patients with fibrolipid and 53.19% with fibrocalcified plaques. DWI was performed before and 24 hours after CAS. RESULTS: Seven (14.89%) patients showed new lesions. Four (8.51%) had 6 new lesions inside the treated vascular territory. Three had a single lesion and 1 patient had 3 lesions (mean: 1.5 ± 1). Most lesions (66.66%) were subcortical, with a mean diameter of 9 mm (range 5-15 mm). All lesions occurred in the area supplied by the middle cerebral artery and were clinically silent. A significant relationship was found between plaque morphology and the appearance of new lesions. Patients with fibrolipid plaques had a significantly higher number of new lesions compared with patients with fibrocalcified plaques (P = .041). The absolute risk of new lesions in the fibrolipid group was 18.18%. CONCLUSIONS: New ischemic lesions were observed in the treated vascular territory in 8.51% of patients. The appearance of new ischemic lesions was significantly related to the plaque morphology. Fibrolipid plaques were associated with higher numbers of new lesions.
BACKGROUND AND PURPOSE:CAS carries an inherent risk of distal cerebral embolization, precipitating new brain ischemic lesions and neurologic symptoms. Our purpose was to evaluate the frequency of new ischemic lesions found on DWI after protected CAS placement and to determine its association with plaque morphology. MATERIALS AND METHODS: Fifty patients (mean age 65.13 ± 7.08 years) with moderate and severe internal carotid artery stenosis underwent CAS with distal filter protection. Fibrolipid and fibrocalcified plaque morphology was determined by sonography according to the relative contribution of echogenic and echolucent material, and by multisection CT using plaque attenuation. There were 46.81% of patients with fibrolipid and 53.19% with fibrocalcified plaques. DWI was performed before and 24 hours after CAS. RESULTS: Seven (14.89%) patients showed new lesions. Four (8.51%) had 6 new lesions inside the treated vascular territory. Three had a single lesion and 1 patient had 3 lesions (mean: 1.5 ± 1). Most lesions (66.66%) were subcortical, with a mean diameter of 9 mm (range 5-15 mm). All lesions occurred in the area supplied by the middle cerebral artery and were clinically silent. A significant relationship was found between plaque morphology and the appearance of new lesions. Patients with fibrolipid plaques had a significantly higher number of new lesions compared with patients with fibrocalcified plaques (P = .041). The absolute risk of new lesions in the fibrolipid group was 18.18%. CONCLUSIONS: New ischemic lesions were observed in the treated vascular territory in 8.51% of patients. The appearance of new ischemic lesions was significantly related to the plaque morphology. Fibrolipid plaques were associated with higher numbers of new lesions.
Authors: Kiran R Nandalur; Erol Baskurt; Klaus D Hagspiel; C Douglas Phillips; Christopher M Kramer Journal: AJR Am J Roentgenol Date: 2005-01 Impact factor: 3.959
Authors: V Lacroix; F Hammer; P Astarci; T Duprez; C Grandin; G Cosnard; A Peeters; R Verhelst Journal: Eur J Vasc Endovasc Surg Date: 2006-12-28 Impact factor: 7.069
Authors: Ralf Zahn; Thomas Ischinger; Bernd Mark; Sabine Gass; Uwe Zeymer; Wolfgang Schmalz; Klaus Haerten; Karl Eugen Hauptmann; Enz-Rüdiger von Leitner; Wolfgang Kasper; Ulrich Tebbe; Jochen Senges Journal: J Am Coll Cardiol Date: 2005-06-07 Impact factor: 24.094
Authors: Joel E Barbato; Ellen Dillavou; Michael B Horowitz; Tudor G Jovin; Emanuel Kanal; Suzanne David; Michel S Makaroun Journal: J Vasc Surg Date: 2008-03-04 Impact factor: 4.268
Authors: V Faraglia; G Palombo; N Stella; M Taurino; M L Iocca; A Romano; A Bozzao Journal: J Cardiovasc Surg (Torino) Date: 2007-12 Impact factor: 1.888
Authors: Péter Szikra; Krisztina Boda; Ferenc Rarosi; Attila Thury; Pál Barzó; Tamás Németh; Erika Vörös Journal: Interv Neuroradiol Date: 2016-02-25 Impact factor: 1.610
Authors: Katrin Wasser; André Karch; Sonja Gröschel; Janin Witzenhausen; Klaus Gröschel; Mathias Bähr; Jan Liman Journal: BMC Neurol Date: 2013-11-05 Impact factor: 2.474